NHS National Pharmaceuticals Transition 2022_1

A Contract Award Notice
by NHS ENGLAND AND NHS IMPROVEMENT

Source
Contracts Finder
Type
Framework (Products)
Duration
22 month
Value
£1-£40M
Sector
HEALTH
Published
12 Aug 2022
Delivery
29 Jul 2022 to 31 May 2024
Deadline
21 Apr 2022 13:00

Concepts

Location

Geochart for 1 buyers and 42 suppliers

1 buyer

42 suppliers

Description

Invitation to offer for NHS National Pharmaceuticals Transition 2022_1 Offer reference number: CM/PHG/21/5637 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum contract length of 48 months. Potential periods of call-offs under the framework agreement: Transition: CESW: 29/07/2022 to 30/09/2023 (14 months) LSNE: 29/07/2022 to 31/05/2024 (22 months) NWLN: 29/07/2022 to 31/01/2023 (6 months) Oral (plus non-parenteral) Products: All regions: 29/07/2022 to 31/05/2024 (22 months) Hospital Only Products: CESW: 29/07/2022 to 30/09/2023 (14 months) LSNE: 29/07/2022 to 31/05/2024 (22 months) NWLN: 29/07/2022 to 31/01/2023 (6 months)

Award Detail

1 Celix Pharma (London)
  • Value: £39,636,345
2 Mylan (Hatfield)
  • Value: £39,636,345
3 Kent Pharma (Ashford)
  • Value: £39,636,345
4 Accord (Barnstaple)
  • Value: £39,636,345
5 Pfizer (Tadworth)
  • Value: £39,636,345
6 Norgine Pharmaceuticals (Uxbridge)
  • Value: £39,636,345
7 Amarox (Harrow)
  • Value: £39,636,345
8 Teva (Castleford)
  • Value: £39,636,345
9 Drreddys Laboratories (Beverley)
  • Value: £39,636,345
10 Napp Pharmaceuticals (Cambridge)
  • Value: £39,636,345
11 Morningside Pharmaeuticals (Loughborough)
  • Value: £39,636,345
12 B Braun Medical (Sheffield)
  • Value: £39,636,345
13 Roma Pharmaceuticals (Burton on Trent)
  • Value: £39,636,345
14 Sandoz (Camberley)
  • Value: £39,636,345
15 Selective Supplies (Watford)
  • Value: £39,636,345
16 Flynn Pharma (Stevenage)
  • Value: £39,636,345
17 Neon Healthcare (Hertford)
  • Value: £39,636,345
18 Flexipharm Austrading (Bourne End)
  • Value: £39,636,345
19 Tillomed Laboratories (Luton)
  • Value: £39,636,345
20 Sintetica (London)
  • Value: £39,636,345
21 Zentiva Pharma (Dunmow)
  • Value: £39,636,345
22 Mercury Pharmaceuticals (London)
  • Value: £39,636,345
23 Glenmark Pharmaceuticals Europe (Watford)
  • Value: £39,636,345
24 Intrapharm Laboratories (Maidenhead)
  • Value: £39,636,345
25 Aspen Pharmacare (Maidenhead)
  • Value: £39,636,345
26 Ranbaxy (Uxbridge)
  • Value: £39,636,345
27 Wockhardt (Wrexham)
  • Value: £39,636,345
28 Medac Pharma (Stirling)
  • Value: £39,636,345
29 Roche Products (Welwyn Garden City)
  • Value: £39,636,345
30 Clinigen Healthcare (Weybridge)
  • Value: £39,636,345
31 Piramal Critical Care (Chesterfield)
  • Value: £39,636,345
32 Milpharm (South Ruislip)
  • Value: £39,636,345
33 Chiesi (Manchester)
  • Value: £39,636,345
34 Consilient Health (Richmond upon Thames)
  • Value: £39,636,345
35 Fresenius Kabi (Runcorn)
  • Value: £39,636,345
36 Alturix (Milton Keynes)
  • Value: £39,636,345
37 Day Lewis Medical (Croydon)
  • Value: £39,636,345
38 Relonchem (Widnes)
  • Value: £39,636,345
39 Ennogen Healthcare (Dartford)
  • Value: £39,636,345
40 Panpharma (Liverpool)
  • Value: £39,636,345
41 Macure Pharma Aps (Copenhagen)
  • Value: £39,636,345
42 Rosemont Pharmaceuticals (Leeds)
  • Value: £39,636,345

CPV Codes

  • 33600000 - Pharmaceutical products

Indicators

  • Contract is suitable for SMEs.

Other Information

Document No. 03 - Framework Agreement and Terms and Conditions - Transition 2022_1 Document No. 03 - Framework Agreement and Terms and Conditions - Transition 2022_1.pdf Transition 2022_1 Transparency Award Schedule 01 Oral Products Transition 2022_1 Transparency Award Schedule 01 Oral Products.pdf Transition 2022_1 Transparency Award Schedule 02 Hospital only Products Transition 2022_1 Transparency Award Schedule 02 Hospital only Products.pdf Parties Appointed to Transition 2022_1 Framework Agreement and SME Status Parties Appointed to Transition 2022_1 Framework Agreement and SME Status.xlsx Transition 2022_1 Transparency Award Schedule 00 Transition Products Transition 2022_1 Transparency Award Schedule 00 Transition Products.pdf

Reference

Domains